Sunlenca solution for injection 463.5mg/1.5ml
Product details
Registration number: SIN17189P
Classification: Prescription Only
Active ingredients: Lenacapavir Sodium eqv Lenacapavir
Strength: 463.5mg/1.5ml
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: GILEAD SCIENCES SINGAPORE PTE. LTD.
ATC code: J05AX31
HSA approval date: 27 February 2025
Manufacturer(s):
- Patheon Italia, S.p.A.
- Hikma Farmaceutica (Portugal) S.A.
Manufacturing country/countries: ITALY; PORTUGAL
What are the HSA registration number and classification for Sunlenca solution for injection 463.5mg/1.5ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17189P
Classification: Prescription Only
What active ingredients and strength are recorded for Sunlenca solution for injection 463.5mg/1.5ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Lenacapavir Sodium eqv Lenacapavir
Strength: 463.5mg/1.5ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Sunlenca solution for injection 463.5mg/1.5ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for Sunlenca solution for injection 463.5mg/1.5ml?
According to the HSA dataset updated 7 August 2026:
Registrant: GILEAD SCIENCES SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for Sunlenca solution for injection 463.5mg/1.5ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Patheon Italia, S.p.A.
- Hikma Farmaceutica (Portugal) S.A.
Manufacturing country/countries: ITALY; PORTUGAL
Where can I look up Sunlenca solution for injection 463.5mg/1.5ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17189P or the exact product name Sunlenca solution for injection 463.5mg/1.5ml. The general register link does not preselect this product.
What are the source dates for this Sunlenca solution for injection 463.5mg/1.5ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Sunlenca solution for injection 463.5mg/1.5ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17189P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)